Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs (Q35834273)
Jump to navigation
Jump to search
scientific article published on 9 July 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs |
scientific article published on 9 July 2015 |
Statements
Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs (English)
Peng Xu
Ying Tong
Xiu-zhen Liu
Ting-ting Wang
Li Cheng
Bo-yu Wang
Xiang Lv
9 July 2015
1 reference
1 reference
1 reference